z-logo
open-access-imgOpen Access
Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention
Author(s) -
Remo H.M. Furtado,
Antônio Fagundes,
Kazuma Oyama,
Thomas A. Zelniker,
Minao Tang,
Julia Kuder,
Sabina A. Murphy,
Andrew Hamer,
Huei Wang,
Anthony Keech,
Robert P. Giugliano,
Marc S. Sabatine,
Brian A. Bergmark
Publication year - 2022
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.121.011382
Subject(s) - medicine , cardiology , mace , percutaneous coronary intervention , conventional pci , myocardial infarction , evolocumab , hazard ratio , cholesterol , lipoprotein , confidence interval , apolipoprotein a1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom